These minor criteria are classically absent in ET, which instead has criteria such as a high VAF of JAK2V617F above 50% and/or the presence of additional nondriver mutations found through NGS, such as NRAS, ZRSR2, U2AF1, and SRSF2 (see Table 1) [46]. This evidence concerns the gene NRAS and essential thrombocythemia.